Aurobindo inks CMO deal for HIV drugs; Quartz Bio signs on with Debiopharm;

> Indian CMO Aurobindo Pharma has signed a deal to manufacture pediatric HIV treatments for public health outfit Medicines Patent Pool. Story

> India is losing its edge in the outsourcing market to other Southeast Asian countries, including the Philippines and Indonesia, according to a report. Article

> Clinical informatics outfit Quartz Bio has signed on with Debiopharm to provide biomarker discovery services. News

> The U.K.'s Medicines and Healthcare Products Regulatory Agency has suspended production at one of Wockhardt's Indian production facilities. Report

> VWR International has bought out contract manufacturer United Biochemicals. Item

> INC Research has appointed PPD veteran Ian Braithwaite as executive vice president of general medicine. More

Suggested Articles

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.